Work starts on £30.5 million cancer treatment centre in Surrey
Construction work has started on a new £30.5 million cancer diagnostic and treatment centre in Guildford.
The facility is being developed in partnership with GenesisCare and Royal Surrey NHS Foundation Trust on the site of Royal Surrey County Hospital.
It is being built by Prime PLC with funding provided by healthcare investment specialist Assura and is expected to be completed in the autumn of 2023.
Assura development director for strategic projects, Jon Webb, said: “As we move beyond the pandemic, the need for more space and capacity for care right across the health system has been clear and this new, state-of-the-art facility is part of that, helping to address treatment backlogs. It’s a special day to see the ground being broken and we look forward to the first patients benefiting from this state-of-the-art site, where such advanced technology will be in use for patients every day.”
READ MORE: Solar car park installed at Surrey Research Park
The facility will provide patients with access to the latest treatment options for cancer, including highly targeted radiotherapy using a Magnetic Resonance Image Linear Accelerator (MR Linac).
MR Linac is not widely available in the UK but has been shown to improve outcomes for tumours that are moving or difficult to reach.
GenesisCare has used this advanced technology to successfully treat renal, pancreatic, and lung tumours at its Oxford centre, where surgery is not possible due to the complexity of the cancer.
Compared to conventional radiotherapy, treatment can be administered with greater sparing of normal tissues, over a shorter period of time, resulting in fewer sessions and less disruption for patients.
Royal Surrey County Hospital will be one of a handful of Trusts to be able to offer access to this technology to its patients.
The development will include PV panels, LED lighting throughout and EV charging points. The site will also benefit from creation of a new sensory garden for patient and staff wellbeing.
Rob Ferris, business development director for Prime said “We are seeing increasing demand for our specialist expertise in securing land, planning and funding for the development of private cancer care facilities, designed to the highest standards for functionality and sustainability. We have collaborated with GenesisCare and Royal Surrey NHS Foundation Trust to deliver a solution that will deliver outstanding benefits to the staff and patients of both organisations and improve health outcomes for the region.”
READ MORE: Biopharma firm Ergomed sees revenues grow by 25 per cent